Latest News and Press Releases

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening...

Psychemedics’ 2025 Insights Report reveals rising synthetic drug threats, industry risk trends, and why hair testing remains the gold standard.

Boston, May 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “High-Throughput Screening: Technologies and Global Markets” is expected to grow from $23.8 billion in 2024...

Psychemedics named “Most Innovative Drug Testing Company of the Year” for advancing hair testing and launching Enhanced Quartile Reporting.

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Drug Abuse Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...

Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Human Liver Model Market by Model Type (2D Models, 3D Models, Ex Vivo Models), Cell Source (Immortalized Liver Cell Lines, Primary Human Hepatocytes,...

Psychemedics proudly announces the launch of its innovative Quartile Reporting feature.

Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing),...